SCHEMBL150283

SCHEMBL150283

Cc1ccc(N)c(N=O)c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.35
▸ TSHR P16473 3/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ TDP1 Q9NUW8 6/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ POLB P06746 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ PIK3CA P42336 1/20 0.33
▸ TDP2 O95551 1/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ PAX8 Q06710 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ GLA P06280 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9404128 0.98 CYP3A4 (0.34) CYP3A4TSHRKMT2AHTTTDP1
SCHEMBL12627630 0.82 CYP3A4 (0.39) CYP3A4TSHRKMT2AHTTTDP1
SCHEMBL5278996 0.77 THRB (0.38) CYP3A4KMT2AHTTTDP1CASP1
SCHEMBL11230056 0.74 HSP90AA1 (0.33) KMT2AMAPTTDP2NSD2HSP90AA1
SCHEMBL8168365 0.73 CD44 (0.50) CYP3A4TSHRKMT2AHTTTDP1
SCHEMBL28165657 0.73 TDP2 (0.37) KMT2AALDH1A1MAPTTDP2NSD2
SCHEMBL14819930 0.72 TSHR (0.49) CYP3A4TSHRKMT2ATDP1ALDH1A1
SCHEMBL14001041 0.72 KMT2A (0.38) CYP3A4TSHRKMT2AHTTALDH1A1
SCHEMBL9394310 0.71 POLB (0.42) CYP3A4TSHRKMT2AHTTTDP1
SCHEMBL12138514 0.70 ALDH1A1 (0.40) CYP3A4TSHRKMT2AHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112409146-B Continuous preparation process of vanillin 南通亚香食品科技有限公司 2023-07-07 — — CN claimed
CN-112409146-A Continuous preparation process of vanillin 南通亚香食品科技有限公司 2021-02-26 — — CN claimed
CN-111747836-A Production process and reaction equipment for synthesizing vanillin from 4-methyl guaiacol 昆山亚香香料股份有限公司 2020-10-09 — — CN claimed
CN-110128644-A A kind of biodegradable polycarbonate-polyester copolymer and preparation method thereof 中国科学院成都有机化学有限公司 2019-08-16 — — CN claimed
CN-105819225-B A kind of preparation method for manganese slag lightweight ceramic tile automatic charging device and its critical component 徐州工程学院 2017-12-26 — — CN claimed
US-7539006-B2 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2009-05-26 — — US claimed
CN-100456398-C Electrolyte for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORP (JP) 2009-01-28 — — CN claimed
US-20070029529-A1 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor KOMATSU AKIHIKO 2007-02-08 — — US claimed
US-20040245105-A1 Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2004-12-09 — — US claimed
CN-1529892-A Electrolyte for driving electrolytic capacitor and electrolytic capacitor 如碧空株式会社 2004-09-15 — — CN claimed
EP-1437749-A1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-07-14 — — EP claimed
CN-1055071-A The photohardenable compositions that contains the resolution that the having of photopolymerization inhibitor improved DU PONT (US) 1991-10-02 — — CN claimed
US-5043237-A Inhibitor-containing photohardenable electrostatic master compositions having improved resolution E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-08-27 — — US claimed
EP-0436948-A2 Inhibitor-containing photohardenable compositions having improved resolution E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-07-17 — — EP claimed
JP-58002831-A — — None — — JP disclosed
US-20250222006-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. (SG) 2025-07-10 — — US disclosed
EP-3795565-B1 IMPROVED PROCESS FOR THE PURIFICATION OF METHYLENE BLUE RK PHARMA INC (US) 2025-07-09 — — EP disclosed
US-4172075-A Fluoro-steroids and processes for their manufacture CIBA-GEIGY CORPORATION (US) 1979-10-23 — — US disclosed
US-3992208-A Photo-sensitive etchant and method for forming metal image using same FUJI PHOTO FILM CO., LTD. (JA) 1976-11-16 — — US disclosed
US-3960559-A Method of making a semiconductor device utilizing a light-sensitive etching agent FUJI PHOTO FILM CO., LTD. (JA) 1976-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250222006-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MB, TPMT, HBB CYP3A4 2022/4885TSHR 1603/4885KMT2A 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback